Edoardo Cignoli : Ranbaxy Stops Ingredient Production at Two Facilities

Indian drug maker Ranbaxy Laboratories said it is temporarily halting ingredient production at two of its facilities. Ranbaxy has come under scrutiny from the U.S. Food and Drug Administration for lax manufacturing norms.



via WSJ.com: US Business http://ift.tt/1hNhv2m